BIAFW — BIOAFFINITY TECHNOLOGIES INC
As of Q2 2026, 2 SEC-registered investment managers reported holding BIAFW (BIOAFFINITY TECHNOLOGIES INC) in their latest 13F filings, with a combined reported value of $8.89K across 63.61K shares. That is -3.6% by share count (-2.35K shares) versus the previous quarter, while reported value moved -67.6%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BIAFW is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| UBS Group AG history | Q2 2026 | 46.45K | $6.50K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 17.16K | $2.39K | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 2 funds)
| Fund | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | 11.71K | 66 | — | 285 | — | — | — | — | 467 | 665 | 48.28K | 48.57K | 47.67K | 46.55K | 46.11K | 46.45K |
| Citadel Advisors | — | — | 15.24K | 28.54K | 25.72K | 24.38K | 24.18K | 22.22K | 39.18K | 50.24K | 35.99K | 32.35K | 30.58K | 23.50K | 19.85K | 17.16K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details